Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 351

1.

Association of CD204+ macrophages with poor outcomes of malignant lymphomas not in remission treated by allo-HCT.

Kawajiri A, Kitano S, Miyagi Maeshima A, Inamoto Y, Tajima K, Takemura T, Tanaka T, Ito A, Okinaka K, Kurosawa S, Kim SW, Taniguchi H, Ogawa C, Izutsu K, Yamamoto N, Fukuda T.

Eur J Haematol. 2019 Sep 5. doi: 10.1111/ejh.13324. [Epub ahead of print]

PMID:
31487403
2.

Retreatment with brentuximab vedotin in patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large-cell lymphoma: a multicenter retrospective study.

Fukuhara N, Yamamoto G, Tsujimura H, Chou T, Shibayama H, Yanai T, Shibuya K, Izutsu K.

Leuk Lymphoma. 2019 Aug 22:1-5. doi: 10.1080/10428194.2019.1654100. [Epub ahead of print] No abstract available.

PMID:
31437057
3.

Rapid and efficient high-performance liquid chromatography analysis of N-nitrosodimethylamine impurity in valsartan drug substance and its products.

Masada S, Tsuji G, Arai R, Uchiyama N, Demizu Y, Tsutsumi T, Abe Y, Akiyama H, Hakamatsuka T, Izutsu KI, Goda Y, Okuda H.

Sci Rep. 2019 Aug 14;9(1):11852. doi: 10.1038/s41598-019-48344-5.

4.

Improved Atomic Force Microscopy Stiffness Measurements of Nanoscale Liposomes by Cantilever Tip Shape Evaluation.

Takechi-Haraya Y, Goda Y, Izutsu K, Sakai-Kato K.

Anal Chem. 2019 Aug 20;91(16):10432-10440. doi: 10.1021/acs.analchem.9b00250. Epub 2019 Aug 7.

PMID:
31390864
5.

Allogeneic haematopoietic stem cell transplantation for primary mediastinal large B-cell lymphoma patients relapsing after high dose chemotherapy with autologous stem cell transplantation: data from the Japan Society for Haematopoietic Cell Transplantation registry.

Kondo E, Shimizu-Koresawa R, Chihara D, Mizuta S, Izutsu K, Ikegame K, Uchida N, Fukuda T, Ichinohe T, Atsuta Y, Suzuki R; Adult Lymphoma Working Group of the JSHCT.

Br J Haematol. 2019 Sep;186(6):e219-e223. doi: 10.1111/bjh.16115. Epub 2019 Jul 29. No abstract available.

PMID:
31355916
6.

Carfilzomib monotherapy in Japanese patients with relapsed or refractory multiple myeloma: A phase 1/2 study.

Iida S, Watanabe T, Matsumoto M, Suzuki K, Sunami K, Ishida T, Ando K, Chou T, Ozaki S, Taniwaki M, Uike N, Shibayama H, Hatake K, Izutsu K, Ishikawa T, Shumiya Y, Tobinai K.

Cancer Sci. 2019 Sep;110(9):2924-2932. doi: 10.1111/cas.14139. Epub 2019 Aug 10.

7.

EBV-encoded RNA1-positive cells in the bone marrow specimens of patients with EBV-negative lymphomas and sarcomas.

Ito Y, Makita S, Maeshima AM, Hatta S, Yuda S, Suzuki T, Fukuhara S, Munakata W, Taniguchi H, Suzuki T, Maruyama D, Izutsu K.

Pathol Int. 2019 Jul;69(7):392-397. doi: 10.1111/pin.12825. Epub 2019 Jul 21.

PMID:
31328350
8.

Multiple myeloma with IGH-FGFR3 rearrangement progressing as testicular plasmacytoma during carfilzomib treatment.

Nakamura N, Maruyama D, Maeshima AM, Saito Y, Fujino T, Ito Y, Hatta S, Makita S, Fukuhara S, Munakata W, Suzuki T, Fujimoto H, Izutsu K.

Ann Hematol. 2019 Oct;98(10):2463-2465. doi: 10.1007/s00277-019-03743-6. Epub 2019 Jun 25. No abstract available.

PMID:
31240468
9.

Viral DNA Loads in Various Blood Components of Patients With Epstein-Barr Virus-Positive T-Cell/Natural Killer Cell Lymphoproliferative Diseases.

Kawada JI, Kamiya Y, Sawada A, Iwatsuki K, Izutsu K, Torii Y, Kimura H, Ito Y.

J Infect Dis. 2019 Sep 13;220(8):1307-1311. doi: 10.1093/infdis/jiz315.

PMID:
31240305
10.

Clinicopathological characteristics of diffuse large B-cell lymphoma involving small and large intestines: an analysis of 126 patients.

Maeshima AM, Taniguchi H, Ito Y, Hatta S, Suzuki T, Yuda S, Makita S, Fukuhara S, Munakata W, Suzuki T, Maruyama D, Izutsu K.

Int J Hematol. 2019 Sep;110(3):340-346. doi: 10.1007/s12185-019-02687-x. Epub 2019 Jun 11.

PMID:
31187439
11.

JSH practical guidelines for hematological malignancies, 2018: II. Lymphoma-1. Follicular lymphoma (FL).

Izutsu K.

Int J Hematol. 2019 Jul;110(1):11-19. doi: 10.1007/s12185-019-02655-5. Epub 2019 Jun 6. No abstract available.

PMID:
31172373
12.

Development of a Paper-Based Luminescence Bioassay for Therapeutic Monitoring of Aminoglycosides: a Proof-of-Concept Study.

Matsuura H, Ujiie K, Duyen TTM, Izutsu K, Fujiyama K, Maeda S, Harada K, Hirata K.

Appl Biochem Biotechnol. 2019 May 23. doi: 10.1007/s12010-019-03048-4. [Epub ahead of print]

PMID:
31119530
13.

[Follicular lymphoma: FL].

Izutsu K.

Rinsho Ketsueki. 2019;60(3):236-237. doi: 10.11406/rinketsu.60.236. Japanese. No abstract available.

PMID:
31068527
14.

Case of follicular lymphoma presenting with nodules and plaques on the face.

Takahashi-Shishido N, Morimura S, Tomita Y, Miyagi-Maeshima A, Fukuhara S, Izutsu K, Sugaya M.

J Dermatol. 2019 Apr 24. doi: 10.1111/1346-8138.14890. [Epub ahead of print] No abstract available.

PMID:
31017687
15.

Draft Genome Sequence of Mycolicibacterium sp. Strain NCC-Tsukiji, Isolated from Blood Culture of a Patient with Malignant Lymphoma.

Fukano H, Yoshida M, Shouji M, Hatta S, Maruyama D, Izutsu K, Shiotsuka M, Ogura Y, Hayashi T, Hasegawa N, Iwata S, Hoshino Y.

Microbiol Resour Announc. 2019 Apr 4;8(14). pii: e01575-18. doi: 10.1128/MRA.01575-18.

16.

AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma.

Leonard JP, Trneny M, Izutsu K, Fowler NH, Hong X, Zhu J, Zhang H, Offner F, Scheliga A, Nowakowski GS, Pinto A, Re F, Fogliatto LM, Scheinberg P, Flinn IW, Moreira C, Cabeçadas J, Liu D, Kalambakas S, Fustier P, Wu C, Gribben JG; AUGMENT Trial Investigators.

J Clin Oncol. 2019 May 10;37(14):1188-1199. doi: 10.1200/JCO.19.00010. Epub 2019 Mar 21.

PMID:
30897038
17.

Analysis of an Impurity, N-Nitrosodimethylamine, in Valsartan Drug Substances and Associated Products Using GC-MS.

Tsutsumi T, Akiyama H, Demizu Y, Uchiyama N, Masada S, Tsuji G, Arai R, Abe Y, Hakamatsuka T, Izutsu KI, Goda Y, Okuda H.

Biol Pharm Bull. 2019 Apr 1;42(4):547-551. doi: 10.1248/bpb.b19-00006. Epub 2019 Feb 7.

18.

Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas.

Kataoka K, Miyoshi H, Sakata S, Dobashi A, Couronné L, Kogure Y, Sato Y, Nishida K, Gion Y, Shiraishi Y, Tanaka H, Chiba K, Watatani Y, Kakiuchi N, Shiozawa Y, Yoshizato T, Yoshida K, Makishima H, Sanada M, Onozawa M, Teshima T, Yoshiki Y, Ishida T, Suzuki K, Shimada K, Tomita A, Kato M, Ota Y, Izutsu K, Demachi-Okamura A, Akatsuka Y, Miyano S, Yoshino T, Gaulard P, Hermine O, Takeuchi K, Ohshima K, Ogawa S.

Leukemia. 2019 Jul;33(7):1687-1699. doi: 10.1038/s41375-019-0380-5. Epub 2019 Jan 25.

PMID:
30683910
19.

High-Dose Chemotherapy with Autologous Stem Cell Transplantation in Primary Central Nervous System Lymphoma: Data From the Japan Society for Hematopoietic Cell Transplantation Registry.

Kondo E, Ikeda T, Izutsu K, Chihara D, Shimizu-Koresawa R, Fujii N, Sakai T, Kondo T, Kubo K, Kato Y, Akasaka T, Fukuda T, Ichinohe T, Atsuta Y, Suzumiya J, Suzuki R; Adult Lymphoma Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant. 2019 May;25(5):899-905. doi: 10.1016/j.bbmt.2019.01.020. Epub 2019 Jan 18.

PMID:
30664936
20.

Effect of surface charge on the size-dependent cellular internalization of liposomes.

Sakai-Kato K, Yoshida K, Izutsu KI.

Chem Phys Lipids. 2019 Jan 17:104726. doi: 10.1016/j.chemphyslip.2019.01.004. [Epub ahead of print]

PMID:
30660745
21.

Detailed Morphological Characterization of Nanocrystalline Active Ingredients in Solid Oral Dosage Forms Using Atomic Force Microscopy.

Sakai-Kato K, Nanjo K, Takechi-Haraya Y, Goda Y, Okuda H, Izutsu KI.

AAPS PharmSciTech. 2019 Jan 10;20(2):70. doi: 10.1208/s12249-018-1259-x.

PMID:
30631974
22.

Applications of Freezing and Freeze-Drying in Pharmaceutical Formulations.

Izutsu KI.

Adv Exp Med Biol. 2018;1081:371-383. doi: 10.1007/978-981-13-1244-1_20. Review.

PMID:
30288720
23.

Paper-based luminescence bioassay method embedding a sequence of enzymatic reactions to detect sulfonamide groups.

Ujiie K, Matsuura H, Thi My Duyen T, Izutsu K, Nitta A, Harada K, Hirata K.

J Antibiot (Tokyo). 2018 Nov;71(12):1044-1047. doi: 10.1038/s41429-018-0094-3. Epub 2018 Aug 23.

PMID:
30139975
24.

Safety, tolerability and pharmacokinetics of shorter duration of infusion of obinutuzumab in Japanese patients with B-cell non-Hodgkin lymphoma: final results of the phase II GATS study.

Ohmachi K, Ando K, Kinoshita T, Kumagai K, Hatake K, Ishikawa T, Teshima T, Kato K, Izutsu K, Ueda E, Nakai K, Kuriki H, Tobinai K.

Jpn J Clin Oncol. 2018 Aug 1;48(8):736-742. doi: 10.1093/jjco/hyy087.

25.

Correction to: Impact of hematopoietic stem cell transplantation in patients with relapsed or refractory mantle cell lymphoma.

Yamasaki S, Chihara D, Kim SW, Izutsu K, Iwato K, Fukuda T, Uchida N, Amano I, Nakazawa H, Kuroda J, Hashimoto H, Ichinohe T, Kanda Y, Atsuta Y, Suzumiya J, Suzuki R.

Ann Hematol. 2018 Oct;97(10):2013-2014. doi: 10.1007/s00277-018-3450-2.

PMID:
30046847
26.

Efficacy and safety of obinutuzumab in patients with previously untreated follicular lymphoma: a subgroup analysis of patients enrolled in Japan in the randomized phase III GALLIUM trial.

Ohmachi K, Tobinai K, Kinoshita T, Ishikawa T, Hatake K, Ichikawa S, Ohmine K, Kamitsuji Y, Choi I, Chou T, Tsukasaki K, Kumagai K, Taniwaki M, Uchida T, Kikukawa Y, Kubo K, Mihara K, Tsukamoto N, Izutsu K, Yoshida I, Ishida F, Usui N, Iida S, Murayama T, Ueda E, Kuriki H, Ando K.

Int J Hematol. 2018 Nov;108(5):499-509. doi: 10.1007/s12185-018-2497-0. Epub 2018 Jul 19.

PMID:
30027429
27.

[III. Novel Agents for Peripheral T-Cell Lymphoma].

Izutsu K.

Gan To Kagaku Ryoho. 2018 May;45(5):806-809. Japanese. No abstract available.

PMID:
30026442
28.

Recurrent 8q24 rearrangement in blastic plasmacytoid dendritic cell neoplasm: association with immunoblastoid cytomorphology, MYC expression, and drug response.

Sakamoto K, Katayama R, Asaka R, Sakata S, Baba S, Nakasone H, Koike S, Tsuyama N, Dobashi A, Sasaki M, Ichinohasama R, Takakuwa E, Yamazaki R, Takizawa J, Maeda T, Narita M, Izutsu K, Kanda Y, Ohshima K, Takeuchi K.

Leukemia. 2018 Dec;32(12):2590-2603. doi: 10.1038/s41375-018-0154-5. Epub 2018 May 23.

PMID:
29795241
29.

Forodesine in the treatment of relapsed/refractory peripheral T-cell lymphoma: an evidence-based review.

Makita S, Maeshima AM, Maruyama D, Izutsu K, Tobinai K.

Onco Targets Ther. 2018 Apr 20;11:2287-2293. doi: 10.2147/OTT.S140756. eCollection 2018. Review.

30.

Successful full-dose DeVIC therapy in a patient with advanced-stage extranodal natural killer/T-cell lymphoma refractory to L-asparaginase.

Watanabe J, Makita S, Ito Y, Hatta S, Suzuki T, Yuda S, Maeshima AM, Fukuhara S, Munakata W, Suzuki T, Maruyama D, Kim SW, Izutsu K.

Ann Hematol. 2018 Sep;97(9):1739-1740. doi: 10.1007/s00277-018-3335-4. Epub 2018 Apr 16. No abstract available.

PMID:
29663028
31.

Exercise intervention implemented by trained volunteers improves health-related quality of life among Japanese community-dwelling older females: an intervention study.

Izutsu K, Arima K, Abe Y, Okabe T, Tomita Y, Mizukami S, Kanagae M, Nishimura T, Aoyagi K.

J Phys Ther Sci. 2017 Dec;29(12):2126-2132. doi: 10.1589/jpts.29.2126. Epub 2017 Dec 7.

32.

Impact of hematopoietic stem cell transplantation in patients with relapsed or refractory mantle cell lymphoma.

Yamasaki S, Chihara D, Kim SW, Izutsu K, Iwato K, Fukuda T, Uchida N, Amano I, Nakazawa H, Kuroda J, Hashimoto H, Ichinohe T, Kanda Y, Atsuta Y, Suzumiya J, Suzuki R.

Ann Hematol. 2018 Aug;97(8):1445-1452. doi: 10.1007/s00277-018-3318-5. Epub 2018 Apr 2. Erratum in: Ann Hematol. 2018 Oct;97(10):2013-2014.

PMID:
29610968
33.

CD3+ CD56+ EBER1+ atypical extraosseous plasmacytoma of the nasal cavity.

Ando Y, Maeshima AM, Fukuhara S, Makita S, Munakata W, Suzuki T, Maruyama D, Taniguchi H, Izutsu K.

Int J Hematol. 2018 Sep;108(3):344-347. doi: 10.1007/s12185-018-2438-y. Epub 2018 Mar 23.

PMID:
29572766
34.

Paraneoplastic Pemphigus Associated with B-cell Chronic Lymphocytic Leukemia Treated with Ibrutinib and Rituximab.

Ito Y, Makita S, Maeshima AM, Hatta S, Suzuki T, Yuda S, Fukuhara S, Munakata W, Suzuki T, Maruyama D, Izutsu K.

Intern Med. 2018 Aug 15;57(16):2395-2398. doi: 10.2169/internalmedicine.0578-17. Epub 2018 Mar 9.

35.

Prevalence of fear of falling and associated factors among Japanese community-dwelling older adults.

Tomita Y, Arima K, Tsujimoto R, Kawashiri SY, Nishimura T, Mizukami S, Okabe T, Tanaka N, Honda Y, Izutsu K, Yamamoto N, Ohmachi I, Kanagae M, Abe Y, Aoyagi K.

Medicine (Baltimore). 2018 Jan;97(4):e9721. doi: 10.1097/MD.0000000000009721.

36.

The Diagnosis of Legionella pneumophila Serogroup 5 Bacteremic Pneumonia during Severe Neutropenia Using Loop-mediated Isothermal Amplification.

Moriguchi S, Abe M, Kimura M, Yoshino C, Baba M, Okada C, Izutsu K, Taniguchi S, Araoka H, Yoneyama A.

Intern Med. 2018 Apr 1;57(7):1045-1048. doi: 10.2169/internalmedicine.9810-17. Epub 2017 Dec 21.

37.

Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma.

Kwong YL, Kim SJ, Tse E, Oh SY, Kwak JY, Eom HS, Do YR, Mun YC, Lee SR, Shin HJ, Suh C, Chuang SS, Lee YS, Lim ST, Izutsu K, Suzuki R, Relander T, d'Amore F, Schmitz N, Jaccard A, Kim WS.

Ann Oncol. 2018 Jan 1;29(1):256-263. doi: 10.1093/annonc/mdx684.

PMID:
29077846
38.

JSH guideline for tumors of hematopoietic and lymphoid tissues-leukemia: 3. Acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LBL).

Takeuchi J, Kusumoto S, Akiyama H, Kanda Y, Izutsu K.

Int J Hematol. 2017 Dec;106(6):732-747. doi: 10.1007/s12185-017-2350-x. Epub 2017 Oct 24. No abstract available.

PMID:
29067593
39.

Treatment for mantle cell lymphoma.

Izutsu K.

Rinsho Ketsueki. 2017;58(10):2026-2032. doi: 10.11406/rinketsu.58.2026. Japanese.

PMID:
28978845
40.

Activation of RHOA-VAV1 signaling in angioimmunoblastic T-cell lymphoma.

Fujisawa M, Sakata-Yanagimoto M, Nishizawa S, Komori D, Gershon P, Kiryu M, Tanzima S, Fukumoto K, Enami T, Muratani M, Yoshida K, Ogawa S, Matsue K, Nakamura N, Takeuchi K, Izutsu K, Fujimoto K, Teshima T, Miyoshi H, Gaulard P, Ohshima K, Chiba S.

Leukemia. 2018 Mar;32(3):694-702. doi: 10.1038/leu.2017.273. Epub 2017 Aug 23.

41.

Phase I/II study of pralatrexate in Japanese patients with relapsed or refractory peripheral T-cell lymphoma.

Maruyama D, Nagai H, Maeda Y, Nakane T, Shimoyama T, Nakazato T, Sakai R, Ishikawa T, Izutsu K, Ueda R, Tobinai K.

Cancer Sci. 2017 Oct;108(10):2061-2068. doi: 10.1111/cas.13340. Epub 2017 Sep 4.

42.

Targeting complete response with upfront bortezomib consolidation versus observation after the achievement of complete response following autologous transplantation for multiple myeloma (TUBA study).

Nakasone H, Terasako-Saito K, Hirano T, Wake A, Shimizu S, Kurita N, Yamazaki E, Usuki K, Akazawa K, Kanda J, Minauchi K, Yamamoto G, Tanimoto S, Kamoshita M, Yokoyama Y, Miyaoka E, Ota S, Kako S, Izutsu K, Kanda Y.

Hematol Oncol. 2018 Feb;36(1):202-209. doi: 10.1002/hon.2452. Epub 2017 Jul 6.

PMID:
28681529
43.

Malignant lymphoma: pathophysiology and current therapy.

Izutsu K.

Rinsho Ketsueki. 2017;58(5):480-486. doi: 10.11406/rinketsu.58.480. Japanese.

PMID:
28592763
44.

Successful Treatment of Pulmonary Mucormycosis Caused by Cunninghamella bertholletiae with High-Dose Liposomal Amphotericin B (10 mg/kg/day) Followed by a Lobectomy in Cord Blood Transplant Recipients.

Ota H, Yamamoto H, Kimura M, Araoka H, Fujii T, Umeyama T, Ohno H, Miyazaki Y, Kaji D, Taya Y, Nishida A, Ishiwata K, Tsuji M, Takagi S, Asano-Mori Y, Yamamoto G, Uchida N, Izutsu K, Masuoka K, Wake A, Yoneyama A, Makino S, Taniguchi S.

Mycopathologia. 2017 Oct;182(9-10):847-853. doi: 10.1007/s11046-017-0149-1. Epub 2017 Jun 2.

PMID:
28577122
46.

A multicenter, single-arm, Phase II clinical trial of bendamustine monotherapy in patients with chronic lymphocytic leukemia in Japan.

Ogawa Y, Izutsu K, Kiguchi T, Choi I, Takatsuka Y, Ando K, Suzumiya J; Japanese Bendamustine CLL Study Group.

Int J Hematol. 2017 May;105(5):631-637. doi: 10.1007/s12185-016-2178-9. Epub 2017 Feb 3.

PMID:
28160213
47.

Identification of cell-type-specific mutations in nodal T-cell lymphomas.

Nguyen TB, Sakata-Yanagimoto M, Asabe Y, Matsubara D, Kano J, Yoshida K, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Izutsu K, Nakamura N, Takeuchi K, Miyoshi H, Ohshima K, Minowa T, Ogawa S, Noguchi M, Chiba S.

Blood Cancer J. 2017 Jan 6;7(1):e516. doi: 10.1038/bcj.2016.122.

48.

Clinical and Microbiological Characteristics of Breakthrough Candidemia in Allogeneic Hematopoietic Stem Cell Transplant Recipients in a Japanese Hospital.

Kimura M, Araoka H, Yamamoto H, Asano-Mori Y, Nakamura S, Yamagoe S, Ohno H, Miyazaki Y, Abe M, Yuasa M, Kaji D, Kageyama K, Nishida A, Ishiwata K, Takagi S, Yamamoto G, Uchida N, Izutsu K, Wake A, Taniguchi S, Yoneyama A.

Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: e01791-16. doi: 10.1128/AAC.01791-16. Print 2017 Apr.

49.

BCL6 locus is hypermethylated in angioimmunoblastic T-cell lymphoma.

Nishizawa S, Sakata-Yanagimoto M, Hattori K, Muto H, Nguyen T, Izutsu K, Yoshida K, Ogawa S, Nakamura N, Chiba S.

Int J Hematol. 2017 Apr;105(4):465-469. doi: 10.1007/s12185-016-2159-z. Epub 2016 Dec 5.

PMID:
27921272
50.

Amorphous-Amorphous Phase Separation of Freeze-Concentrated Protein and Amino Acid Excipients for Lyophilized Formulations.

Izutsu KI, Yoshida H, Shibata H, Goda Y.

Chem Pharm Bull (Tokyo). 2016;64(12):1674-1680.

Supplemental Content

Loading ...
Support Center